Matisse Capital’s BlackRock Science and Technology Term Trust BSTZ Stock Holding History

Matisse Capital’s Portfolio BSTZ Stock Details BSTZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-98,400	Closed	-$1.96M	–	180
2024 Q2	$1.96M	Sell	98,400 -41,600	-30%	-$780K	0.97%	24
2024 Q1	$2.72M	Buy	140,000 +5,000	+4%	+$89.8K	1.31%	10
2023 Q4	$2.26M	Buy	135,000 +55,000	+69%	+$889K	1.2%	13
2023 Q3	$1.32M	Hold	80,000	–	–	0.93%	23
2023 Q2	$1.45M	Hold	80,000	–	–	0.9%	23
2023 Q1	$1.5M	Hold	80,000	–	–	0.97%	21
2022 Q4	$1.25M	Buy	+80,000	New	+$1.36M	1.11%	31
2021 Q2	–	Sell	-98,000	Closed	-$3.5M	–	150
2021 Q1	$3.5M	Buy	+98,000	New	+$3.57M	1.01%	38

Other funds holding BSTZ

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

PCR

Potrero Capital Research San Francisco, California $163M AUM 79.07% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Matisse Capital's BSTZ Position: Q3 2024 in Review

Matisse Capital sold out of BlackRock Science and Technology Term Trust (BSTZ) in Q3 2024, closing a stake of 98,400 shares — an estimated $1.96M sold.

Matisse Capital first reported a position in BSTZ in Q1 2021 and held it in 8 quarters. The position peaked at $3.5M in Q1 2021. 101 funds tracked by Wall St. Rank hold BSTZ as of Q3 2024.

Matisse Capital reported no remaining BlackRock Science and Technology Term Trust position as of Q3 2024 after selling out during the quarter.
Matisse Capital sold 98,400 BlackRock Science and Technology Term Trust shares in Q3 2024, an estimated $1.96M.
Matisse Capital first reported a position in BlackRock Science and Technology Term Trust in Q1 2021 and held it in 8 quarters.
Matisse Capital's BlackRock Science and Technology Term Trust position peaked at $3.5M in Q1 2021.
101 funds tracked by Wall St. Rank held BlackRock Science and Technology Term Trust as of Q3 2024.

Based on Matisse Capital's 13F filing for Q3 2024, filed 17 Oct 2024.